MTIPAlternative Names: CRHR1 receptor antagonist (MTIP) - Eli Lilly
Latest Information Update: 30 Apr 2013
At a glance
- Originator Eli Lilly
- Mechanism of Action Corticotropin releasing factor receptor 1 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Alcoholism
Most Recent Events
- 30 Apr 2013 Discontinued - Phase-I for Alcoholism in USA (PO)
- 31 Dec 2009 Phase-I clinical trials in Alcoholism in USA (PO)
- 21 Oct 2009 Pharmacodynamics data from a preclinical trial in rodents presented at the 39th Annual Meeting of the Society for Neuroscience (SfN-2009)